ZappRx scores $25 mln Series B
Boston-based ZappRx Inc, a provider of a platform for electronic prescriptions, has raised $25 million in Series B funding. Qiming US Healthcare Fund led the round with participation from other investors that included SR One and GV. In addition to the funding, Mark McDade, a managing partner at Qiming US, has been appointed to ZappRx's board of directors.
20 April 2017•1 min read
